Barclays’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Barclays’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,000	Closed	-$57K	–	7406
2018 Q4	$57K	Hold	5,000	–	–	﹤0.01%	5406
2018 Q3	$200K	Buy	+5,000	New	+$142K	﹤0.01%	5004

Barclays's MRNS Position: Q1 2025 in Review

Barclays sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 54 shares — an estimated $29 sold.

Barclays first reported a position in MRNS in Q1 2018 and held it in 20 quarters. The position peaked at $4.44M in Q1 2023. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

Barclays reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
Barclays sold 54 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $29.
Barclays first reported a position in Marinus Pharmaceuticals, Inc in Q1 2018 and held it in 20 quarters.
Barclays's Marinus Pharmaceuticals, Inc position peaked at $4.44M in Q1 2023.
0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.